# Sub-Clinical Atrial Fibrillation Biomarker Study

> **NCT02840201** · — · COMPLETED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 321 (actual)

## Conditions studied

- Subclinical Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02840201
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-26
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02840201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02840201, "Sub-Clinical Atrial Fibrillation Biomarker Study". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT02840201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*